Showing 1 - 16 results of 16 for search 'Guangrong Zheng', query time: 0.05s
Refine Results
-
1
Persistent fifth aortic arch: a comprehensive literature review by Haiyan Shan, Xiaolan Du, Guangrong Zheng, Tengfei Ke, Chengde Liao, Haiyan Yang
Published 2023-06-01
Article -
2
-
3
Targeted degradation of specific TEAD paralogs by small molecule degraders by Hui Chen, Artem Gridnev, Netanya Schlamowitz, Wanyi Hu, Kuntala Dey, Guangrong Zheng, Jyoti R. Misra
Published 2024-09-01
Article -
4
-
5
Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells by Guochen Li, Haiyan Yang, Tengfei Ke, Na Tan, Xiaolan Du, Xirui Duan, Xinyan Zhou, Guangrong Zheng, Chengde Liao
Published 2025-02-01
Article -
6
-
7
Publisher Correction: Factors associated with overdiagnosis of benign pulmonary nodules as malignancy: a retrospective cohort study by Xirui Duan, Zhiqiang Ouyang, Shasha Bao, Lu Yang, Ailin Deng, Guangrong Zheng, Yu Zhu, Guochen Li, Jixiang Chu, Chengde Liao
Published 2023-12-01
Article -
8
-
9
-
10
Tumor perfusion enhancement by focus ultrasound-induced blood-brain barrier opening to potentiate anti-PD-1 immunotherapy of glioma by Haiyan Shan, Guangrong Zheng, Shasha Bao, Haiyan Yang, Ujen Duwal Shrestha, Guochen Li, Xirui Duan, Xiaolan Du, Tengfei Ke, Chengde Liao
Published 2024-11-01
Article -
11
Evaluation of functional magnetic resonance APT and DKI imaging for breast cancer by Haiyan Shan, Tengfei Ke, Shasha Bao, Yifan Liu, Na Tan, Xinyan Zhou, Guochen Li, Guangrong Zheng, Yongzhou Xu, Yu Xie, Chengde Liao, Jun Yang
Published 2024-12-01
Article -
12
A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR by Song Han, Gerik W. Tushoski-Alemán, Peiyi Zhang, Guangrong Zheng, Daohong Zhou, Zhiguang Huo, Jonathan Licht, Thomas J. George, Carmen Allegra, Jose G. Trevino, Steven J. Hughes
Published 2025-01-01
Article -
13
Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL by Digant Nayak, Dongwen Lv, Yaxia Yuan, Peiyi Zhang, Wanyi Hu, Anindita Nayak, Eliza A. Ruben, Zongyang Lv, Patrick Sung, Robert Hromas, Guangrong Zheng, Daohong Zhou, Shaun K. Olsen
Published 2024-03-01
Article -
14
Co-targeting BCL-XL and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice by Sajid Khan, Patrick Kellish, Nick Connis, Dinesh Thummuri, Janet Wiegand, Peiyi Zhang, Xuan Zhang, Vivekananda Budamagunta, Nan Hua, Yang Yang, Umasankar De, Lingtao Jin, Weizhou Zhang, Guangrong Zheng, Robert Hromas, Christine Hann, Maria Zajac-Kaye, Frederic J. Kaye, Daohong Zhou
Published 2023-01-01
Article -
15
Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells by Yannan Jia, Lina Han, Cassandra L. Ramage, Zhe Wang, Connie C. Weng, Lei Yang, Simona Colla, Helen Ma, Weiguo Zhang, Michael Andreeff, Naval Daver, Nitin Jain, Naveen Pemmaraju, Kapil Bhalla, Satu Mustjoki, Peiyi Zhang, Guangrong Zheng, Daohong Zhou, Qi Zhang, Marina Konopleva
Published 2023-04-01
Article -
16
Targeting BCL-XL in fibrolamellar hepatocellular carcinoma by Bassem Shebl, Denise Ng, Gadi Lalazar, Carly Rosemore, Tova M. Finkelstein, Rachael D. Migler, Guangrong Zheng, Peiyi Zhang, Caroline S. Jiang, Adam Qureshi, Roger Vaughan, Mark Yarchoan, Ype P. de Jong, Charles M. Rice, Philip Coffino, Michael V. Ortiz, Daohong Zhou, Sanford M. Simon
Published 2022-09-01
Article